What's On: Novartis, Monsanto, Washington Post
Here's what's up on Wednesday's Squawk on the Street:
--The CEO of Novartis joins us. This company has a lot going on including a ground-breaking new drug designed to fight Multiple Sclerosis.
--We're also getting quarterly results from Monsanto, we'll have the numbers and instant stock reaction.
--Then the $300 a share club is talking about Washington Post's stock.
--Plus meet some college students that are beating the S&P handily over the last few years — they'll reveal the secrets to their success.
--Then, what's your tipping point? More high profile CNBC guests and commentators are saying they'd give up entitlements like Social Security and Medicare to save the country from a financial crisis. Would you?
--And meet the authors of a new book called "XXL: Obesity and the Limits of Shame." They're proposing government sponsored vouchers to help people fight fat. Vouchers would go to pay for diet programs, healthier food and more. Would you support it? Share your opinion, and watch the big show at 9 a.m. ET on the dot — profit from it.